Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Poveda

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
AIDS Reviews|September 16, 2010
Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonistsEva Poveda, José Alcamí, Roger Paredes, et al.
BMC Public Health|October 23, 2019
Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective studySulaiman Lakoh, Darlinda F Jiba, Joseph E Kanu, et al.
AIDS Reviews|July 27, 2012
Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonistsEva Poveda, Roger Paredes, Santiago Moreno, et al.
Antiviral Research|June 12, 2012
No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patientsFederico Alejandro Di Lello, Juan Macias, Zulema Plaza, et al.
ACS Omega|December 27, 2021
Aptamer Sandwich Assay for the Detection of SARS-CoV-2 Spike Protein AntigenMarketa Svobodova, Vasso Skouridou, Miriam Jauset-Rubio, et al.
Basic & Clinical Pharmacology & Toxicology|November 3, 2018
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabinePurificación Cid-Silva, Noelia Fernández-Bargiela, Luis Margusino-Framiñán, et al.
Global Health Action|August 18, 2021
Assessing eligibility for differentiated service delivery, HIV services utilization and virologic outcomes of adult HIV-infected patients in Sierra Leone: a pre-implementation analysisSulaiman Lakoh, Darlinda F Jiba, Alren O Vandy, et al.
AIDS (London, England)|March 8, 2011
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patientsPablo Labarga, Vincent Soriano, Antonio Caruz, et al.
The Journal of Infectious Diseases|February 15, 2023
Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1Eva Poveda, Wendy Fitzgerald, Cristina Reglero, et al.
Genes|September 28, 2021
Characterizing HIV-1 Genetic Subtypes and Drug Resistance Mutations among Children, Adolescents and Pregnant Women in Sierra LeoneGeorge A Yendewa, Sulaiman Lakoh, Sahr A Yendewa, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
AIDS Reviews|September 16, 2010
Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonistsEva Poveda, José Alcamí, Roger Paredes, et al.
BMC Public Health|October 23, 2019
Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective studySulaiman Lakoh, Darlinda F Jiba, Joseph E Kanu, et al.
AIDS Reviews|July 27, 2012
Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonistsEva Poveda, Roger Paredes, Santiago Moreno, et al.
Antiviral Research|June 12, 2012
No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patientsFederico Alejandro Di Lello, Juan Macias, Zulema Plaza, et al.
ACS Omega|December 27, 2021
Aptamer Sandwich Assay for the Detection of SARS-CoV-2 Spike Protein AntigenMarketa Svobodova, Vasso Skouridou, Miriam Jauset-Rubio, et al.
Basic & Clinical Pharmacology & Toxicology|November 3, 2018
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabinePurificación Cid-Silva, Noelia Fernández-Bargiela, Luis Margusino-Framiñán, et al.
Global Health Action|August 18, 2021
Assessing eligibility for differentiated service delivery, HIV services utilization and virologic outcomes of adult HIV-infected patients in Sierra Leone: a pre-implementation analysisSulaiman Lakoh, Darlinda F Jiba, Alren O Vandy, et al.
AIDS (London, England)|March 8, 2011
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patientsPablo Labarga, Vincent Soriano, Antonio Caruz, et al.
The Journal of Infectious Diseases|February 15, 2023
Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1Eva Poveda, Wendy Fitzgerald, Cristina Reglero, et al.
Genes|September 28, 2021
Characterizing HIV-1 Genetic Subtypes and Drug Resistance Mutations among Children, Adolescents and Pregnant Women in Sierra LeoneGeorge A Yendewa, Sulaiman Lakoh, Sahr A Yendewa, et al.
Pageof 15